MS4A2 rs569108: Understanding Genetic Links to Childhood Asthma
The rs569108 variant is a specific change in the MS4A2 gene that has been studied for its potential role in immune system function. Research has identified an association between this variant and an increased predisposition to childhood asthma within Japanese populations.
What each genotype means
Unknown risk profile
There is currently insufficient scientific evidence to determine the specific health implications of this genotype. Research regarding this variant has primarily focused on the association of the C allele with asthma risk in specific populations, but the clinical significance of the homozygous C/C state remains unclear.
This genotype is observed in the general population, though specific frequency data varies by ancestry.
Increased asthma risk
Research in Japanese populations has associated this genotype with a 3-fold increased risk of predisposition to childhood asthma. This association is specific to certain ancestral groups, and you should discuss any respiratory concerns or family history with your clinician.
The C allele has a global minor allele frequency of approximately 0.1194, making this heterozygous genotype relatively common in some populations.
Normal risk profile
This genotype is considered the normal or baseline state for this variant in the context of the studied asthma associations. It does not carry the increased risk observed in individuals who possess the C allele in certain populations.
This is the most common genotype for this variant in many global populations.
What is rs569108?
The variant rs569108 is a single nucleotide polymorphism (SNP) located on chromosome 11. In the context of human genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is situated within the MS4A2 gene, which provides instructions for creating a protein involved in the body's immune response. Scientists track these variations to understand how subtle differences in our genetic code might influence susceptibility to complex health conditions. Because rs569108 is located in a region associated with immune regulation, it has been a subject of interest for researchers investigating the genetic architecture of allergic and respiratory diseases.
The Role of the MS4A2 Gene
The MS4A2 gene encodes the beta subunit of the high-affinity IgE receptor. This receptor plays a critical role in the immune system, particularly in the allergic response. When the body encounters an allergen, IgE antibodies bind to these receptors on the surface of specific immune cells, triggering the release of chemicals that cause inflammation and symptoms associated with allergies and asthma. Because MS4A2 is central to this signaling pathway, variations in the gene sequence are hypothesized to potentially alter the sensitivity or intensity of the immune response. Understanding how the MS4A2 protein functions helps researchers piece together why some individuals may be more prone to airway inflammation and wheezing than others.
Research and Evidence Strength
The evidence linking rs569108 to health outcomes is considered moderate and is notably ancestry-specific. Published studies have observed that the C allele of this SNP is associated with a 3-fold increased risk of predisposition to childhood asthma in Japanese populations. It is important to note that genetic associations are often complex and can vary significantly between different ethnic groups due to differences in genetic background and environmental exposures. While these findings provide valuable insights into the biological pathways of asthma, they do not imply a direct cause-and-effect relationship for every individual. The scientific community continues to study how this variant interacts with other genetic and environmental factors to influence the development of respiratory conditions.
Population Frequency
The frequency of genetic variants can differ widely across global populations. For rs569108, the reported global minor allele frequency is approximately 0.1194. This means that the variant is present in a notable portion of the population, though its prevalence and its specific association with health outcomes are not uniform worldwide. Because genetic studies are often conducted within specific cohorts, the observed risk associated with rs569108 in Japanese populations may not be replicated in other ancestral groups. This highlights the importance of diversity in genomic research to ensure that findings are accurately interpreted across all human populations.
Interpreting Your Genetic Information
If you have information about your genotype for rs569108, it is essential to view it within the context of your overall health and family history. Genetic variants are only one piece of a much larger puzzle that includes lifestyle, environment, and other genetic factors. This information is for educational purposes and should not be used to diagnose or predict the development of asthma. If you have concerns about respiratory health, asthma symptoms, or your family's medical history, please consult with a qualified healthcare provider or a clinical geneticist. They can provide personalized guidance based on your clinical presentation rather than relying on a single genetic marker.
How common is this variant?
The global minor allele frequency for rs569108 is 0.1194. The distribution of this variant varies across different ancestral populations.
Frequently asked questions
Does having the rs569108 variant mean I will develop asthma?
No, having a specific genotype for rs569108 does not mean you will develop asthma. Asthma is a complex condition influenced by many genes, environmental factors, and lifestyle choices, and this variant is only one small factor among many.
Is rs569108 the only gene associated with asthma?
No, asthma is a polygenic condition, meaning it is associated with many different genes and variants. Research has identified numerous genetic loci that contribute to the risk of developing asthma.
Can I use this information to change my asthma treatment?
No, you should never change your medical treatment or medication based on genetic information alone. Always discuss your asthma management plan and any concerns about your health with your clinician or pharmacist.
Why is the risk associated with rs569108 different in some populations?
Genetic associations can vary between populations due to differences in genetic background, evolutionary history, and environmental interactions. A finding in one population does not always translate to the same risk in another.
Sources & further reading
Educational information only, last refreshed 9/23/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs569108?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29